ADVENT TECHNOLOGIES HOLDINGS (ADN) Company Report

Stockholders of Advent Technologies Holdings Inc. (ADN) approved the election of three directors (Mark Zilenfran, Seth Lukesh, and Joseph Celia) to serve until the 2028 Annual Meeting.
The appointment of M and K CPAs P, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Shareholders approved the potential issuance and sale of 20% or more of the company's common stock to Hudson Global Ventures LLC, for up to $52,000,000.
An amendment to the 2021 incentive plan was approved, increasing the number of shares issuable under the plan from 530,976 to 1,011,627, with provisions for annual increases starting January 1, 2027.
Stockholders approved the compensation of named executive officers and voted for a three-year frequency for future advisory votes on executive compensation.

Oct 22, 2025, 1:00 PM

Advent Technologies Holdings Inc. Stockholders Approve Director Elections, Stock Issuance, and Incentive Plan Amendment

ADN

Proxy Vote Outcomes

Board Change

Executive Compensation

Advent Technologies Holdings Inc. held its Annual Meeting of Stockholders on October 22, 2025, with 39.73% of outstanding shares represented, establishing a quorum.
Stockholders approved the election of three Class II directors (Mark Tillenfriend, Seth Lukash, and Joseph Silia) to serve until the 2028 annual meeting, and ratified M&K CPAS, PLLC as the independent registered public accounting firm for fiscal year 2025.
The potential issuance and sale of 20% or more of the company's common stock to Hudson Global Ventures LLC, for up to $52 million, was approved by stockholders.
An amendment to the 2021 Incentive Plan was approved, increasing the number of shares issuable from 530,976 to 1,011,627 and incorporating provisions for annual increases.
Stockholders also approved the compensation of named executive officers and determined that advisory votes on executive compensation will occur every three years.